NanoHive Medical is a company specializing in 3D-printed titanium spinal interbody fusion devices. The company's flagship product line, the Hive portfolio, utilizes proprietary Soft Titanium technology to create interbody fusion devices with biomechanical elastic modulus properties comparable to PEEK while providing similar load-bearing strength as bone. NanoHive's patented rhombic dodecahedron lattice structure creates a base similar to cancellous bone, stimulates bone formation, and provides ideal biomechanical properties. The company's products are designed to address challenges in spinal fusion procedures, offering features such as clear diagnostic imaging capability, osteoblast cell attraction, and integration.
NanoHive's product portfolio includes various spinal fusion devices such as the Hive Standalone ALIF System, Hive Cervical System, and Hive Standalone Cervical System. In January 2023, the company received FDA 510(k) clearance for its Hive Standalone Cervical System. NanoHive has been expanding its product offerings through line extensions and new product launches. In April 2023, the company was awarded a Federal Supply Schedule Contract by the US Department of Veteran Affairs, granting access to its complete line of 3D printed Hive interbody devices for the Veteran's Health Administration. NanoHive is also engaged in research and development of "smart" sensor implant technology, collaborating with DirectSync Surgical to develop a stimulating/sensing 3D printed interbody fusion cage.
Key customers and partnerships
NanoHive Medical has established partnerships with several companies to expand its market reach. In February 2022, the company entered into a distribution agreement with Accelus to broaden the distribution of its Hive Soft Titanium 3D printed interbody fusion technology in the US. This collaboration aimed to increase NanoHive's market penetration, particularly in outpatient and ambulatory care surgery center facilities.
NanoHive also distributes its products through a network of independent distributors and has a strategic partnership with Precision Spine, Inc. In April 2023, the company secured a supply schedule contract with the US Department of Veteran Affairs, allowing it to supply its Hive interbody devices to the largest healthcare system in the US, serving over 9 million enrolled veterans. Additionally, in October 2023, NanoHive Medical announced a collaboration with DirectSync Surgical to develop a stimulating/sensing 3D printed interbody fusion cage, aiming to integrate patient-powered stimulation into Hive implants and provide surgeons with post-operative data analysis tools.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.